Latest

Jetstream Venture Fund Secures Position in Rejuvenate Bio, Investing Alongside Industry Giant Merck

SCOTTSDALE, Ariz., June 16, 2026 /PRNewswire/ -- Jetstream Venture Fund (Jetstream), an innovative interval fund dedicated to opening access to institutional-grade deal flow for a wider mainstream audience, today announced it has established an investment interest in Rejuvenate Bio. This strategic move allows Jetstream to secure early-stage positioning alongside
Jetstream Venture Fund
Clinical Labs Review Proposed Legislation To Modernize Oversight of Lab-Developed Tests Under CLIA

Clinical Labs Review Proposed Legislation To Modernize Oversight of Lab-Developed Tests Under CLIA

SALT LAKE CITY, June 16, 2026 /PRNewswire/ -- Clinical laboratories, including ARUP Laboratories, are reviewing newly introduced federal legislation to modernize oversight of laboratory-developed tests (LDTs) under the Clinical Laboratory Improvement Amendments (CLIA), the framework for regulation of laboratory testing in the United States. On May 19, Rep. Neal Dunn,
ARUP Laboratories